Video

HFSA 24: EXPANDed: Atrial Secondary MR Outcomes Following TEER

Published: 01 Oct 2024

  • Views:

    Views Icon 25
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

HFSA Congress 2024 - Dr Mark Ricciardi (NorthShore Cardiovascular Institute, US) joins us to discuss the findings from the EXPANDed real-world clinical trial on mitral transcatheter edge-to-edge repair with the MitraClip System.

The study is designed to confirm the safety and performance of the MitraClip NTR and XTR Systems in mTEER procedures. 1000 patients across 60 sites in Europe and the US are enrolled in the study.

Interview Questions:

  1. What is the reasoning for this trial?
  2. What is the study design and patient population?
  3. What are the key outcomes?
  4. What is your main take-home message?
  5. What further study is needed?

Recorded remotely from Chicago, 2024.

Editorial Manager: Brad Wilson
Editor: Jordan Rance
Video Specialist: David Ben-Harosh

Comments

You must be to comment. If you are not registered, you can register here.